He appeared in federal court in Virginia and faces health care and wire fraud, kickback, and money laundering conspiracy charges. Between 2016 and 2019, prosecutors say, Satary controlled Clio Laboratories in Georgia, Performance Laboratories in Oklahoma, and Lazarus Services in Louisiana. Most of the claimed amount came from Performance, which prosecutors said billed Medicare $413 million after enrolling as a provider in late 2018. Clio allegedly billed $121 million and Lazarus at least $13 million. Satary was originally charged during Operation Double Helix, a 2019 crackdown in which 35 defendants allegedly billed Medicare more than $2.1 billion for unnecessary genetic tests.